Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-8 of 8
Keywords: Factor VIla
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Pathophysiology of Haemostasis and Thrombosis (1996) 26 (Suppl. 1): 31–34.
Published Online: 28 April 2009
...Egon Persson Des(1-38)- and des(1-44)-factor Vila (fVIIa) were inhibited with Phe-Phe-Arg-chloromethyl ketone (FFR-cmk). Des(1-38)-FFR-fVIIa inhibited tissue factor (TF)-enhanced fVIIa amidolytic activity with an IC 50 value of 15 n M , whereas 3-and 6-fold higher values were obtained with des(1-44...
Journal Articles
Pathophysiology of Haemostasis and Thrombosis (1996) 26 (Suppl. 1): 66–71.
Published Online: 28 April 2009
...James H. Morrissey Factor VIla (FVIIa) is the triggering enzyme of the blood clotting cascade in hemostasis and thrombosis and may play an important role in hypercoagulable states. Indeed, certain epidemiologic studies have found elevated FVII coagulant activity to be an independent risk factor...
Journal Articles
Pathophysiology of Haemostasis and Thrombosis (1996) 26 (Suppl. 1): 72–75.
Published Online: 28 April 2009
...Kenneth A. Bauer; Sabine Eichinger; Pier M. Mannucci; Robert D. Rosenberg To evaluate the mechanism responsible for the generation of factor VIla in vivo, we measured the levels of this enzyme after administering purified factor IX concentrates to patients with hemophilia B. Their factor VIla...
Journal Articles
J. Ingerslev, D. Freidman, D. Gastineau, G. Gilchrist, H. Johnsson, G. Lucas, J. McPherson, E. Preston, E. Scheibel, M. Shuman
Pathophysiology of Haemostasis and Thrombosis (1996) 26 (Suppl. 1): 118–123.
Published Online: 28 April 2009
... inhibitors have complicated the clinical picture, and in whom a surgical procedure was indicated. As part of a compassionate use program devised by the producer of this genetically engineered factor VIla, 12 patients underwent life-saving or essential surgery where the recombinant factor VIla product...
Journal Articles
Pathophysiology of Haemostasis and Thrombosis (1996) 26 (Suppl. 1): 83–91.
Published Online: 28 April 2009
...Fletcher B. Taylor, Jr. Anti-tissue factor antibody and active site-inhibited factor VIla inhibit both the disseminated intravascular coagulant response to LD 100 Escherichia coli and its lethal inflammatory effects. In contrast, active site inhibited factor Xa while completely inhibiting...
Journal Articles
Pathophysiology of Haemostasis and Thrombosis (1996) 26 (Suppl. 1): 155–158.
Published Online: 28 April 2009
...Kenneth A. Bauer Factor VII deficiency is a relatively infrequent hereditary bleeding disorder. Recombinant factor VIla has been used to treat patients with factor VII deficiency with bleeding episodes or undergoing surgery. The drug has shown a high efficacy rate and will provide factor VH...
Journal Articles
Pathophysiology of Haemostasis and Thrombosis (1983) 13 (3): 198–200.
Published Online: 21 April 2009
...W.A. Deijk; M.C.E. van Dam-Mieras; A.D. Muller A preliminary report suggests a correlation between metastatic prostate cancer and increased plasma factor Vila levels. Prostate cancer without metastases and prostate hypertrophy showed no clear pattern in factor VIla. Further investigations...
Journal Articles
Pathophysiology of Haemostasis and Thrombosis (1983) 13 (3): 186–191.
Published Online: 21 April 2009
... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Factor VII Factor Vila Cold activation factor VII Blood transfusion Blood bank procedures Haemostasis 13: 186-191...